merck kgaa - Search News

News

Merck KGaA to Buy US Drugmaker Springworks

Reuters on MSN · 2h

Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks

Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 billion to add rare cancer therapies ahead of expected revenue losses linked to expiring patents.

Yahoo Finance · 4h

Merck KGaA strikes $3.9bn deal for SpringWorks

Merck KGaA (Merck) has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks Therapeutics. Under the deal, Merck will pay $47 per share in cash,

Investopedia on MSN · 4h

Germany's Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around $3.9 billion, expanding its portfolio of rare disease and cancer treatments.

1h

Temu, Tesla prices, Merck KGaA deal: Trending Tickers

Online retailer Temu — owned by PDD Holdings (PDD) — aims to raise prices amid tariffs, while Tesla (TSLA) raises its EV ...

Fierce Pharma39m

Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks

Merck KGaA’s long courtship of SpringWorks Therapeutics has come to fruition as the German drugmaker has bought out the ...

Contract Pharma42m

Marck KGaA Agrees to Acquire SpringWorks

Merck KGaA, Darmstadt, Germany, a science and technology company, has entered into a definitive agreement to acquire ...

The Pharma Letter2h

Merck to acquire rare diseases company SpringWorks

After reported discussions since February, German pharma and sciences company Merck KGaA (MRK: DE) has confirmed its ...

9h

Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business

Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc.

3d

EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition

EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results